Rigel Pharmaceuticals, Inc. (RIGL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.72
Day's range
$29.26

Rigel Pharmaceuticals Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 1.77 M $47.83 M   6.29% 9.61%
ARMISTICE CAPITAL, LLC 05/15/2026 1.28 M $34.61 M   53.11% 6.95%
STATE STREET CORP 05/15/2026 1.12 M $30.29 M   2.66% 6.08%
05/15/2026 764.19 K $20.66 M   100.00% 4.15%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 666.43 K $18.01 M   35.01% 3.62%
LSV ASSET MANAGEMENT 05/11/2026 601.51 K $16.27 M   10.51% 3.27%
MARSHALL WACE, LLP 05/15/2026 598.38 K $16.18 M   -2.48% 3.25%
AMERICAN CENTURY COMPANIES INC 05/15/2026 544.43 K $14.72 M   113.93% 2.96%
D. E. SHAW & CO., INC. 05/15/2026 445.68 K $12.05 M   5.03% 2.42%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 440.63 K $11.92 M   3.84% 2.39%
GOLDMAN SACHS GROUP INC 05/15/2026 439.10 K $11.87 M   -34.65% 2.38%
TWO SIGMA INVESTMENTS, LP 05/15/2026 405.81 K $10.97 M   49.62% 2.20%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 379.54 K $10.26 M   37.11% 2.06%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 343.90 K $9.30 M   19.30% 1.87%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 338.44 K $9.15 M   -37.21% 1.84%
NUVEEN, LLC 04/30/2026 337.43 K $9.12 M   30.33% 1.83%
MILLENNIUM MANAGEMENT LLC 05/15/2026 264.41 K $7.15 M   -38.72% 1.44%
CM MANAGEMENT, LLC 05/08/2026 235.00 K $6.35 M   4.44% 1.28%
GLOBEFLEX CAPITAL L P 05/13/2026 217.84 K $5.89 M   0.00% 1.18%
TREXQUANT INVESTMENT LP 05/15/2026 216.41 K $5.85 M   9.77% 1.18%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 176.85 K $4.78 M   18.98% 0.96%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 167.34 K $4.52 M   -59.55% 0.91%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 151.31 K $3.89 M   147.88% 0.82%
05/08/2026 147.54 K $3.99 M   100.00% 0.80%
BANK OF AMERICA CORP /DE/ 05/18/2026 144.13 K $3.90 M   23.24% 0.78%
JANUS HENDERSON GROUP PLC 05/18/2026 135.88 K $3.67 M   275.16% 0.74%
NORTHERN TRUST CORP 05/14/2026 134.57 K $3.64 M   4.30% 0.73%
CITADEL ADVISORS LLC 05/15/2026 131.20 K $3.55 M   -29.24% 0.71%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 05/13/2026 125.66 K $3.40 M   16.37% 0.68%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 124.01 K $3.35 M   100.00% 0.67%
PACER ADVISORS, INC. 06/18/2026 114.39 K $3.09 M   74.62% 0.62%
FRANKLIN RESOURCES INC 05/13/2026 113.88 K $3.08 M   177.60% 0.62%
BANK OF NEW YORK MELLON CORP 05/05/2026 99.92 K $2.70 M   -7.71% 0.54%
MORGAN STANLEY 05/15/2026 98.87 K $2.67 M   -40.62% 0.54%
BURNEY CO/ 04/29/2026 91.68 K $2.48 M   100.00% 0.50%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 91.01 K $2.46 M   -17.07% 0.49%
LOS ANGELES CAPITAL MANAGEMENT LLC 05/08/2026 89.64 K $2.42 M   35.69% 0.49%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 83.13 K $2.25 M   -23.01% 0.45%
EMPOWERED FUNDS, LLC 06/16/2026 82.62 K $2.23 M   100.00% 0.45%
FMR LLC 05/15/2026 79.97 K $2.16 M   17.89% 0.43%
RITHOLTZ WEALTH MANAGEMENT 04/20/2026 78.39 K $2.12 M   -2.74% 0.43%
MAN GROUP PLC 05/15/2026 78.02 K $2.11 M   37.63% 0.42%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 75.07 K $2.02 M   1.65% 0.41%
JANE STREET GROUP, LLC 05/12/2026 70.21 K $1.90 M   -74.55% 0.38%
OPALEYE MANAGEMENT INC. 05/15/2026 70.00 K $1.89 M   0.00% 0.38%
FIRST TRUST ADVISORS LP 05/13/2026 66.67 K $1.80 M   2.84% 0.36%
HENNION & WALSH ASSET MANAGEMENT, INC. 05/13/2026 66.24 K $1.79 M   26.93% 0.36%
PRUDENTIAL FINANCIAL INC 05/13/2026 64.41 K $1.74 M   -52.44% 0.35%
INSPIRE INVESTING, LLC 04/23/2026 63.89 K $1.73 M   100.00% 0.35%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 56.50 K $1.53 M   -0.88% 0.31%

Rigel Pharmaceuticals institutional Ownership - FAQ's

During the previous two years, 252 institutional investors and hedge funds held shares of Rigel Pharmaceuticals. The most heavily invested institutionals were:

LSV ASSET MANAGEMENT: 721,666

Bank of New York Mellon Corp: 108,209

Hennion & Walsh Asset Management, Inc.: 87,844

Russell Investments Group, Ltd.: 76,002

BURNEY CO/: 55,769

Universal- Beteiligungs- und Servicegesellschaft mbH: 55,200

86.92% of Rigel Pharmaceuticals stock is owned by institutional investors.

Institutional investors have bought a total of 35.35 M shares in the last 24 months. This purchase volume represents approximately $992.14 M in transactions.